GIUSTINA, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 20.868
AS - Asia 8.708
EU - Europa 7.053
SA - Sud America 1.607
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 21
Totale 38.417
Nazione #
US - Stati Uniti d'America 20.666
CN - Cina 3.190
SG - Singapore 2.856
UA - Ucraina 2.587
BR - Brasile 1.348
HK - Hong Kong 1.187
DE - Germania 1.042
PL - Polonia 773
FI - Finlandia 559
VN - Vietnam 473
GB - Regno Unito 429
FR - Francia 391
IE - Irlanda 368
TR - Turchia 368
RU - Federazione Russa 362
IT - Italia 313
IN - India 244
CA - Canada 115
BD - Bangladesh 98
AR - Argentina 85
ZA - Sudafrica 62
MX - Messico 56
SE - Svezia 54
EC - Ecuador 47
IQ - Iraq 45
PY - Paraguay 35
ID - Indonesia 34
ES - Italia 31
JP - Giappone 28
CZ - Repubblica Ceca 27
BE - Belgio 25
IR - Iran 25
SA - Arabia Saudita 25
MA - Marocco 23
CO - Colombia 22
CL - Cile 21
NL - Olanda 21
EU - Europa 20
PK - Pakistan 20
UZ - Uzbekistan 20
AU - Australia 19
VE - Venezuela 19
PE - Perù 18
AT - Austria 17
AE - Emirati Arabi Uniti 14
KE - Kenya 12
NP - Nepal 12
AZ - Azerbaigian 10
JO - Giordania 10
JM - Giamaica 8
KZ - Kazakistan 8
LT - Lituania 8
IL - Israele 7
PT - Portogallo 7
DZ - Algeria 6
HN - Honduras 6
TN - Tunisia 6
UY - Uruguay 6
BO - Bolivia 5
EG - Egitto 5
ET - Etiopia 5
MU - Mauritius 5
RO - Romania 5
CI - Costa d'Avorio 4
EE - Estonia 4
MY - Malesia 4
PA - Panama 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CH - Svizzera 3
GE - Georgia 3
KR - Corea 3
LV - Lettonia 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
CM - Camerun 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MN - Mongolia 2
SV - El Salvador 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BN - Brunei Darussalam 1
CY - Cipro 1
GD - Grenada 1
GR - Grecia 1
HR - Croazia 1
Totale 38.400
Città #
Fairfield 3.211
Woodbridge 2.446
Houston 1.752
Jacksonville 1.741
Ashburn 1.705
Singapore 1.412
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.222
Hong Kong 1.178
Wilmington 1.112
Warsaw 770
Princeton 689
Nanjing 637
Beijing 622
Chandler 515
Dublin 367
New York 303
Istanbul 296
Nanchang 256
Los Angeles 237
Helsinki 203
Moscow 201
The Dalles 201
Des Moines 185
Ho Chi Minh City 169
Shenyang 166
Buffalo 156
Changsha 142
San Diego 131
Hebei 127
São Paulo 118
Tianjin 116
Jiaxing 112
Hanoi 109
Redondo Beach 104
Milan 95
Munich 80
Kunming 72
Shanghai 71
Chicago 68
Jinan 68
San Francisco 59
Brescia 55
Dallas 54
Dearborn 49
Hangzhou 49
Verona 47
Lancaster 44
Rio de Janeiro 40
London 39
Toronto 38
San Mateo 37
Lanzhou 36
Johannesburg 35
Kocaeli 35
Santa Clara 34
Haikou 33
Brooklyn 31
Guangzhou 31
Zhengzhou 31
Montreal 30
Turku 30
Ningbo 29
Boardman 28
Dong Ket 28
Leawood 28
Tokyo 28
Atlanta 27
Belo Horizonte 27
Dhaka 25
Mexico City 25
Brussels 24
Poplar 24
Augusta 23
Phoenix 22
Taizhou 22
Curitiba 21
Denver 21
Porto Alegre 21
Brasília 20
Brno 20
Manchester 20
Stockholm 20
Quito 19
Ardabil 18
Changchun 18
Council Bluffs 18
Ankara 17
Biên Hòa 17
Boston 17
Tashkent 17
Asunción 16
Charlotte 16
Taiyuan 16
Washington 16
Salvador 15
Da Nang 14
Guayaquil 14
Orange 14
Totale 27.352
Nome #
Elevated intraocular pressure in patients with acromegaly 329
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 297
Ghrelin regulates proliferation and differentiation of osteoblastic cells 250
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 217
Guidelines for acromegaly management. 205
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 188
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 176
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 175
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 173
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 172
Growth hormone deficiency in treated acromegaly 172
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 172
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 169
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 169
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 169
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 167
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 159
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 157
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 155
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 155
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 154
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 154
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 153
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 146
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 145
A consensus on criteria for cure of acromegaly. 144
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 143
Diagnosis and treatment of acromegaly complications. 141
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 141
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 141
The management of the patient with acromegaly and headache: a still open clinical challenge. 140
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 140
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 140
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 139
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 139
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 138
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 138
Pituitary testing: a reappraisal. 136
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 135
High prevalence of radiological vertebral fractures in HIV-infected males 135
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 135
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 135
Cardiovascular risk in aging and obesity: is there a role for GH. 135
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 134
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 134
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 134
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 134
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 134
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 133
Guidelines for acromegaly management: an update. 132
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 132
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 131
Growth hormone deficiency in the adult. 130
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 130
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 130
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 130
A consensus on criteria for cure acromegaly 129
Prevalence of vertebral fractures in men with acromegaly 127
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 127
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 127
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 127
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 127
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 126
New understanding and treatments for osteoporosis. 126
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 126
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 126
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 126
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 126
Expert consensus document:A consensus on the medical treatment of acromegaly 126
Octreotide for acromegaly treatment: a reappraisal. 126
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 125
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 125
Growth hormone in glucocorticoid-induced osteoporosis. 125
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 125
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 125
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 125
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 125
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 125
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 124
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 124
New oral anticoagulants and pituitary apoplexy 124
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 123
Glucocorticoids and the regulation of growth hormone secretion. 123
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. 122
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 122
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies. 121
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 121
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 121
Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. 120
TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. 120
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 119
Influence of diabetes mellitus on vertebral fractures in men with acromegaly. 119
Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. 119
Somatostatin analogs selective for subtyps 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenoma cells cultured in vitro. 118
Current guidelines for adult GH replacement. 118
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 118
Erectile dysfunction and coronary artery disease in patients with diabetes. 118
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 118
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 118
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 117
Totale 14.210
Categoria #
all - tutte 176.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 176.460


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.572 0 0 0 0 0 619 210 679 729 519 643 173
2021/20222.426 136 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20265.714 991 1.283 686 1.460 874 420 0 0 0 0 0 0
Totale 38.699